CELC Market Cap History



Below is a table of the CELC market cap history going back to 9/20/2017:

Date CELC Market Cap
9/20/2017133.91M
11/6/2017215.25M
2/28/2018175.25M
5/1/2018193.65M
8/1/2018245.19M
11/5/2018288.62M
2/21/2019240.83M
4/29/2019225.62M
7/31/2019233.04M
11/1/2019158.30M
3/5/202074.44M
5/1/202056.73M
6/30/202071.30M
11/2/202056.53M
2/5/2021154.46M
5/3/2021365.37M
8/2/2021301.23M
11/1/2021288.29M
3/15/2022123.84M
5/9/202293.05M
8/8/2022156.14M
11/3/2022154.60M
3/15/2023221.23M
5/8/2023206.19M
8/4/2023231.06M
11/6/2023247.84M
3/20/2024541.76M
5/8/2024549.96M
8/7/2024594.31M

Also see: CELC Shares Outstanding History
and CELC YTD Return
CELC Historical Market Cap:
+24.17% CAGR
CELC Historical Market Cap: +24.17% CAGR

Mouse over chart for data details
9/20/2017 ...8/7/2024
Celcuity is a clinical-stage biotechnology company focused on developing targeted therapies for treatment of multiple solid tumor indications. Co.'s main therapeutic candidate is gedatolisib, a pan-PI3K/mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other approved and investigational therapies that target PI3K or mTOR alone or together. Co.'s therapeutic candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all Class I isoforms of PI3K and mammalian target of rapamycin. We show 29 historical shares outstanding datapoints in our CELC shares outstanding history coverage, used to compute CELC market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CELC market cap history over the course of time is important for investors interested in comparing CELC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CELC versus a peer is one thing; comparing CELC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CELC can fluctuate over the course of history. With this page we aim to empower investors researching CELC by allowing them to research the CELC market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CELC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celcuity (CELC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CELG Market Cap History
CELL Market Cap History
CELZ Market Cap History
CEMI Market Cap History
CERC Market Cap History
CERE Market Cap History
CERS Market Cap History
CFMS Market Cap History
CFRX Market Cap History
CGEM Market Cap History
More Healthcare companies »

 

CELC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.